Research

Green background with word Clinical Trial Alert and a picture of scientists in a lab
Blog Post

Clinical Trial Alert: Phase 3 Study of IgPro20 in Adults with Dermatomyositis

By Sujatha Gurunathan | August 17, 2022
Blog Post

Simply Stated: What is Myasthenia Gravis (MG)?

By Sujatha Gurunathan | June 27, 2022
Man in an electric wheelchair on a footpath in a suburban setting.
Featured Article

Understanding Amyotrophic Lateral Sclerosis

By MDA Staff | May 13, 2022
Scientific conference speakers
Featured Article

A Successful In-Person Conference

By MDA Staff | May 13, 2022
Blog Post

Promoting Diversity in Rare Disease Research

By Larry Luxner | April 8, 2022
Featured Article

Family Inheritance

By Amy Bernstein | February 16, 2022
Blog Post

Capricor Announces Positive Results from its Phase 2 Study of CAP-1002 to Treat DMD

By Sujatha Gurunathan | September 30, 2021
Blog Post

Scholar Rock Announces Positive Results from Interim Analysis of TOPAZ Phase 2 Study of SRK-015 to Treat SMA

By Sujatha Gurunathan | October 28, 2020
Blog Post

FDA Approves NS Pharma’s Viltepso for Treatment of DMD Amenable to Exon 53 Skipping

By MDA Staff | August 12, 2020
Blog Post

FDA Approves Genentech’s Evrysdi for Treatment of SMA in Pediatric and Adult Patients

By MDA Staff | August 7, 2020